Across
- 2. Loss of eyebrows seen commonly in advanced leprosy
- 3. Paucibacillary form with strong cell mediated immunity
- 5. Inability to close eyelids due to facial nerve involvement
- 7. Peripheral nerve most commonly thickened in leprosy
- 9. National programme responsible for leprosy control in India
- 12. Instrument used to assess protective sensation
- 13. Daily drug used in multidrug therapy for leprosy
- 15. Most bactericidal drug in MDT given as supervised monthly dose
- 16. Multibacillary form characterized by numerous symmetrical lesions
- 17. Another name for Type 1 lepra reaction causing nerve inflammation
- 18. Single dose chemoprophylaxis given to contacts of MB cases
Down
- 1. Reduced sensation seen over leprosy skin lesions
- 4. Deformity caused by common peroneal nerve palsy
- 6. Visible deformity used as an indicator of delayed detection
- 8. Type 2 lepra reaction presenting with painful nodules and fever
- 10. Bacterium responsible for causing leprosy
- 11. MDT drug known to cause reddish brown skin pigmentation
- 14. Online portal used for leprosy case reporting in India